Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Probiotics in Cancer

Version 1 : Received: 4 August 2020 / Approved: 5 August 2020 / Online: 5 August 2020 (09:27:01 CEST)

How to cite: Lu, K.; Wu, X.; Jin, R.; Chen, H. Probiotics in Cancer. Preprints 2020, 2020080116 (doi: 10.20944/preprints202008.0116.v1). Lu, K.; Wu, X.; Jin, R.; Chen, H. Probiotics in Cancer. Preprints 2020, 2020080116 (doi: 10.20944/preprints202008.0116.v1).

Abstract

In recent years, the consumption of over-the-counter probiotics used to promote health has grown rapidly worldwide and become an industry. In medicine, various studies have proven that probiotics can help improve the immune system and intestinal health. They are usually safe, but in some rare cases, they may cause concerning adverse reactions. Although the use of probiotics has been widely popularized in the public, the results of many probiotics clinical trials are contradictory. Especially for the cancer patients, the feasibility of probiotics management to provide benefits by targeting cancer and lessening anti-cancer side effects requires further investigations. And this review summarizes the interactions between probiotics and the host and current pros and cons of applying probiotics in the cancer patients.

Subject Areas

probiotics; cancer; safety; clinical trials

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.